...
首页> 外文期刊>The Journal of laboratory and clinical medicine >Endothelin-1 urinary excretion, but not endothelin-1 plasma concentration, is increased in renovascular hypertension.
【24h】

Endothelin-1 urinary excretion, but not endothelin-1 plasma concentration, is increased in renovascular hypertension.

机译:在肾血管性高血压中,内皮素-1的尿排泄量增加,但内皮素-1的血浆浓度却没有增加。

获取原文
获取原文并翻译 | 示例

摘要

Animal experiments have shown an increase in prepro-endothelin-1 (prepro-ET-1) mRNA expression in the clipped kidney but none in the aortic and mesenteric arteries in 2-kidney, 1-clip Goldblatt hypertensive rats. The present study was aimed at investigating whether plasma and renal endothelin-1 (ET-1) systems are differently activated in patients with renovascular hypertension (RH). The plasma concentration and urinary excretion of ET-1 were measured in 5 patients with RH (before and after successful renal angioplasty), in 7 patients with essential hypertension (EH), and in 8 normotensive control subjects. Immediately before renal angioplasty, plasma samples for ET-1 and plasma renin activity (PRA) measurements were withdrawn from the aorta and both renal veins. Unlike the PRA, the plasma ET-1 concentration did not significantly differ between the involved and the uninvolved sides. The urinary ET-1 excretion level (Fig 1) was markedly increased in patients with RH (30+/-4 ng/g urinary creatinine (UC) vs. 2.5+/-0.2 ng/g UC and 2.6+/-0.5 ng/g UC in control subjects and patients with EH, respectively; P<.001), whereas the plasma ET-1 concentration was normal (0.8+/-0.2 pg/mL vs. 0.65+/-0.3 pg/mL and 0.8+/-0.2 pg/mL in control subjects and EH, respectively, not significant). Renal angioplasty was followed in all patients by normalization of blood pressure and PRA. One week after angioplasty, urinary ET-1 decreased to one fourth of baseline (8.04+/-5.23 ng/g UC, P<.001 vs. values before angioplasty and P<.04 vs. control subjects) and normalized 1 month thereafter (3.13+/-1.62 ng/g UC, not significant vs. control subjects), whereas plasma ET-1 remained steady. The present findings clearly indicate that in patients with RH, urinary ET-1 excretion is increased, whereas plasma ET-1 concentration remains normal. Successful percutaneous transluminal renal angioplasty induced a notable reduction in ET-1 urinary excretion, whereas it did not affect ET-1 plasma concentration.
机译:动物实验显示,在2肾1夹Goldblatt高血压大鼠的肾脏中,前内皮素-1(prepro-ET-1)mRNA表达增加,但在主动脉和肠系膜动脉中无表达。本研究旨在研究在肾血管性高血压(RH)患者中血浆和肾脏内皮素-1(ET-1)系统是否被不同地激活。在5例RH患者(成功的肾脏血管成形术前后),7例原发性高血压(EH)患者和8例血压正常对照者中测量了ET-1的血浆浓度和尿排泄。在即将进行肾血管成形术之前,从主动脉和两条肾静脉中取出用于ET-1和血浆肾素活性(PRA)测量的血浆样品。与PRA不同,受累侧和未受累侧的血浆ET-1浓度均无显着差异。 RH患者的尿ET-1排泄水平(图1)显着增加(30 +/- 4 ng / g尿肌酐(UC)与2.5 +/- 0.2 ng / g UC和2.6 +/- 0.5 ng / g UC分别在对照组和EH患者中; P <.001),而血浆ET-1浓度正常(0.8 +/- 0.2 pg / mL,而0.65 +/- 0.3 pg / mL和0.8+在对照受试者和EH中分别为±0.2 pg / mL,无显着性)。所有患者均通过血压和PRA正常化进行肾脏血管成形术。血管成形术后一周,尿ET-1降至基线的四分之一(8.04 +/- 5.23 ng / g UC,P <.001 vs.血管成形术之前的值,P <.04 vs.对照组),此后1个月恢复正常(3.13 +/- 1.62 ng / g UC,与对照组相比无统计学意义),而血浆ET-1保持稳定。目前的发现清楚地表明,在RH患者中,尿ET-1排泄增加,而血浆ET-1浓度保持正常。成功的经皮腔内肾血管成形术可显着减少ET-1尿液排泄,但不影响ET-1血浆浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号